Stage IV Colorectal Cancer: Gene's Survivor Story

Patient Info: Gene Jones, Male, 50s | Stage IV

Metastatic Site: Liver; lung

As of July 2023, Gene was an 81-year-old, 30-year Stage IV colon cancer survivor with no active colon cancer reported after chemotherapy, cryoablation/liver surgery, later liver surgery, and left-lung surgery.

MD AndersonRead more →

Stage I Triple-Negative Breast Cancer: Melissa's Survivor Story

Patient Info: Melissa Berry, Female, 40s | Stage I

Biomarkers: BRCA mutation reported; triple-negative breast cancer

As of July 2023, Melissa was a 10-year Stage I triple-negative breast cancer survivor with no recurrence reported.

The Patient StoryRead more →

Melissa’s Stage 1 Triple-Negative Breast Cancer Story

Patient Info: Melissa Berry, Female, 40s | Stage I

Biomarkers: BRCA-positive carrier status; ER-negative; PR-negative; HER2-negative

Melissa described herself as a 10-year triple-negative breast cancer survivor and said she remained without evidence of disease, with annual oncology follow-up.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Michelle's Patient Story

Patient Info: Michelle Cappel, Female, 40s | Stage IV

Metastatic Site: Leg/femoral nerve area

As of July 2023, Michelle was living with recurrent Stage IV colorectal cancer after prior NED, leg/femoral-nerve recurrence, radiation, surgery with clear margins, and ongoing surveillance.

The Patient StoryRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Megan's Survivor Story

Patient Info: Megan Claire Chase, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2 not reported

As of July 2023, Megan-Claire was in survivorship after Stage II invasive lobular breast cancer, with clear early scans but significant long-term effects, surgical menopause, chronic pain, fatigue, chemo brain, and inability to tolerate recurrence-prevention medications.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Michelle's Survivor Story

Patient Info: Michelle Cappel, Female, 40s | Stage IV

Biomarkers: Lynch syndrome negative; no hereditary genetic markers reported

Metastatic Site: Ovary

As of July 2023, Michelle had achieved no evidence of disease after FOLFOX chemotherapy and 12-hour surgery for Stage IV colorectal cancer with ovarian metastasis, while continuing to live with scan anxiety and surveillance.

The Patient StoryRead more →

Stage II Invasive Lobular Carcinoma: Megan-Claire's Survivor Story

Patient Info: Megan-Claire, Female, Under 40 | Stage II

As of July 2023, Megan-Claire had completed chemotherapy, breast-conserving surgery with reconstruction/reduction, and 33 radiation rounds, and was living with long-term effects including neuropathy, scarring, fatigue, and radiation trauma; no recurrence or NED status was stated.

The Patient StoryRead more →

Megan-Claire: Stage II Breast Cancer, invasive lobular treatment and follow-up story

Patient Info: Megan-Claire, Female, 40s | Stage II

As of July 2023, Megan-Claire was in survivorship after Stage II invasive lobular breast cancer, with ongoing post-treatment quality-of-life issues and a strong focus on self-advocacy and survivorship care.

The Patient StoryRead more →

Rectal cancer managed with active surveillance in a patient with inflammatory bowel disease

Patient Info: Anonymized, Female

No local recurrence or systemic disease was detected throughout surveillance, and she remained disease-free 9 years after rectal-cancer treatment.

PubMed CentralRead more →

Stage III Inflammatory Breast Cancer: Nikki's Patient Story

Patient Info: Nikki, Female, 40s | Stage III

Biomarkers: Hormone-positive

As of July 2023, Nikki had completed 7 chemotherapy rounds for Stage III inflammatory hormone-positive breast cancer, had no sign of distant spread on PET scans, and was preparing for single mastectomy, radiation, and long-term hormone therapy.

The Patient StoryRead more →

Stage III HER2-Positive Inflammatory Breast Cancer: Nikki's Patient Story

Patient Info: Nikki, Female | Stage III

Biomarkers: HER2-positive; hormone receptor-positive

After 7 chemotherapy rounds, imaging showed no visible disease, but the team expected possible microscopic cancer. A single mastectomy, radiation and long-term hormone therapy were still planned, so she was not classified as cancer-free.

The Patient StoryRead more →

MET-mutated lung cancer: testing savolitinib before surgery — Case 2

Patient Info: Anonymized, Female, 60s

Biomarkers: MET exon 14 skipping mutation; PD-L1 expression 75%

Savolitinib produced approximately 72% tumour shrinkage. Surgery found 30% viable residual tumour, negative lymph nodes and ypT1bN0M0 disease; she recovered without complications and continued savolitinib.

PubMed CentralRead more →

MET-mutated lung cancer: testing savolitinib before surgery

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: MET exon 14 skipping, TP53 and BRAF mutations; PD-L1 expression 5%

Metastatic Site: pleura; mediastinal lymph node

Savolitinib produced a partial radiological response, but surgery confirmed persistent pleural and mediastinal nodal metastases with ypStage IVA disease. He recovered and continued adjuvant savolitinib.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Lucinda's Patient Story

Patient Info: Lucinda Rudolph, Female, 60s

As of June 2023, Lucinda was living well after treatment for locally advanced recurrent invasive lobular breast cancer, taking exemestane, receiving supportive care for neuropathy, and returning to MD Anderson every 6 months for checkups.

MD AndersonRead more →

Colorectal Cancer: Maria's Patient Story

Patient Info: Maria Dupree, Female, 50s

As of June 2023, Maria had recovered well from robotic anterior resection for proximal rectal cancer and had undergone additional chemotherapy; no formal stage, biomarker result, metastatic disease, or NED status is stated.

Cleveland ClinicRead more →

My Colorectal Cancer Story: How I Changed My Diet After Cancer

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica was all-clear after 5 years following Stage III bowel cancer treatment and described survivorship changes in diet, exercise, rest, stress, and emotional healing.

The Patient StoryRead more →

Stage III Colorectal Cancer: Angelica's Survivor Story

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica had received her 5-year all-clear after Stage III bowel cancer treatment; later colonoscopy surveillance was reassuring and a liver cyst had disappeared.

The Patient StoryRead more →

Stage II Colorectal Cancer: Wendy's Survivor Story

Patient Info: Wendy Tamis Robbins, 50s | Stage II

Wendy was cancer-free and in surveillance with regular scans and check-ups after surgery and chemotherapy.

Dana-FarberRead more →

Stage III Invasive Lobular Carcinoma: Neda's Survivor Story

Patient Info: Neda, Female, 40s | Stage III

Neda had completed surgery, 24 CMF treatments and 25 radiation treatments. She was regaining energy, had started endocrine therapy and was preparing to add another recurrence-reduction medicine.

Lobular Breast Cancer AllianceRead more →

Stage III Breast Cancer: Sarah's Patient Story

Patient Info: Sarah, Female, 40s | Stage III

Biomarkers: Estrogen/progesterone-sensitive breast cancer mentioned; exact receptor labels not reported

As of June 2023, Sarah had lived through incurable salivary gland cancer and Stage III breast cancer, completed major breast cancer treatment, paused hormone therapy to pursue IVF under medical guidance, delivered her daughter at 48, and was advocating for people with cancer; no cancer-free or NED status was stated.

The Patient StoryRead more →

Stage III HR-Positive Breast Cancer: Sarah's Survivor Story

Patient Info: Sarah McDonald, Female, 40s | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative

Sarah was 10 years from diagnosis without a recurrence and described the breast cancer as successfully treated. She later paused hormone therapy, completed IVF and gave birth at age 48.

The Patient StoryRead more →

BRCA1 Breast Cancer: Carol's Survivor Story

Patient Info: Carol Arnhart

Biomarkers: BRCA1 mutation

She had a complete pathologic response to breast chemotherapy and later reported no evidence of breast cancer.

MD AndersonRead more →

Stage I BRCA1 Ovarian Cancer: Carol's Survivor Story

Patient Info: Carol Arnhart | Stage I

Biomarkers: BRCA1 mutation

After staging surgery and 6 rounds of carboplatin and paclitaxel, she reported no evidence of ovarian cancer.

MD AndersonRead more →

My Stage 4 Colorectal Cancer Story: How I Never Lost Hope

Patient Info: Jason Randall, Male | Stage IV

Metastatic Site: Liver; lungs; bone/sacrum

As of June 2023, Jason had a negative Signatera test, CT scans showing 9 months with no evidence of disease, and about 2.5 years off chemotherapy after Stage IV colorectal cancer treatment and lung ablation.

The Patient StoryRead more →